JULIA TAYLOR: Open Payments
NPI 1336248129 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,481 in 123 payments from 17 companies in 2025. Trend: 2023 $2,483 · 2024 $3,917 · 2025 $2,481
Food & beverage: $2,401Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $586 |
| ABBVIE INC. | 32 | $473 |
| UCB, Inc. | 18 | $414 |
| Amgen Inc. | 13 | $220 |
| Lilly USA, LLC | 7 | $168 |
| PFIZER INC. | 11 | $152 |
| Janssen Scientific Affairs, LLC | 1 | $133 |
| E.R. Squibb & Sons, L.L.C. | 3 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $57 |
| Galderma Laboratories, L.P. | 2 | $38 |
Products named: TREMFYA, Bimzelx, Otezla, SKYRIZI, RINVOQ, CIBINQO, EBGLYSS, Sotyktu.
Industry payments across WA — which companies pay providers there.
